Baicalin relieves complement alternative pathway activation-induced lung inflammation through inhibition of NF-κB pathway
Baicalin relieves complement alternative pathway activation-induced lung inflammation by inhibition of NF-κB pathway, delaying the progression of ALI.
Authors
- Qiao-Zhou Liu
- Qian‐Yun Sun (ORCID: https://orcid.org/0000-0001-9691-2028)
- Min Li (ORCID: https://orcid.org/0000-0003-1330-2326)
- Qing‐Yu Lu
- Jiao Li (ORCID: https://orcid.org/0000-0003-4386-2340)
- Li Guo (ORCID: https://orcid.org/0000-0001-5624-5259)
- Qi-Yun Zhang
Institutions
- Guiyang Medical University (CN)
- Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences (CN)
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1186/s12906-024-04622-y
- Citations
- 8
- Primary Topic
- Flavonoids in Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 3.58
Funders
- National Natural Science Foundation of China